One of the main challenges in RAD51C research is the variability in the clinical significance of different mutations. Not all RAD51C mutations confer the same level of risk, and some may have uncertain significance. More research is needed to understand the full spectrum of RAD51C mutations and their implications. Additionally, integrating genetic testing into routine clinical practice poses logistical and ethical challenges.
